ClinicalTrials.Veeva

Menu

Transcranial Direct Current Stimulation (tDCS) as a Cognitive Functioning Enhancement Treatment for ADHD Patients Compared to Healthy Controls

H

Hebrew University of Jerusalem

Status

Completed

Conditions

Transcranial Direct Current Stimulation

Treatments

Device: Sham
Device: Transcranial Direct Current Stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT04697316
tDCS-ADHD

Details and patient eligibility

About

This study will examine the possible effects of tDCS (Transcranial Direct Current Stimulation) treatment to the left DLPFC on cognitive functions which were found to be deficient amongst ADHD patients. The study will include 100 subjects, 50 of whom diagnosed with ADHD. Subjects will complete the ASRS questionnaire to measure ADHD symptoms severity. Next, subjects will complete a series of cognitive tasks, after which they will receive either tDCS treatment or a sham treatment. Finally, subjects will repeat the cognitive tasks. Later that day, a telephonic follow up will take place. ADHD symptoms will be assessed again the next day.

Enrollment

63 patients

Sex

All

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:Participation criteria for healthy participants

  1. Right hand dominance.
  2. No psychiatric nor neural diagnosis.
  3. Participants must be able to comprehend the study's procedure and sign an informed consent.

Participation criteria for ADHD diagnosed participants

  1. ADHD diagnosis (according to DSM V).

  2. Right hand dominance.

  3. Participants must be able to comprehend the study's procedure and sign an informed consent.

  4. Participants who regularly use Methylphenidate will be required to avoid the medication for 24 hours prior to study and 12 hours post study.

Exclusion Criteria:

  • a. Other psychiatric diagnoses (additional to ADHD). b. Drug use (excluding Methylphenidate). c. Neurological disorders. d. Pacemaker, Insulin pump

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

63 participants in 4 patient groups

ADHD tDCS
Experimental group
Treatment:
Device: Transcranial Direct Current Stimulation
ADHD Sham
Sham Comparator group
Treatment:
Device: Sham
Healthy control tDCS
Experimental group
Treatment:
Device: Transcranial Direct Current Stimulation
Healthy control Sham
Sham Comparator group
Treatment:
Device: Sham

Trial contacts and locations

1

Loading...

Central trial contact

Noa Beiman

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems